Literature DB >> 9643772

Azithromycin, the multidrug-resistant protein, and cystic fibrosis.

E L Altschuler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9643772     DOI： 10.1016/S0140-6736(05)79350-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Macrolide immunomodulation of chronic respiratory diseases.

Authors:  Daniel P Healy
Journal:  Curr Infect Dis Rep       Date:  2007-01       Impact factor: 3.725

Review 2.  Mechanisms of action and clinical application of macrolides as immunomodulatory medications.

Authors:  Soichiro Kanoh; Bruce K Rubin
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

3.  Influence of a macrolide antibiotic, roxithromycin, on mast cell growth and activation in vitro.

Authors:  T Shimane; K Asano; M Suzuki; T Hisamitsu; H Suzaki
Journal:  Mediators Inflamm       Date:  2001-12       Impact factor: 4.711

4.  Interest of colchicine for the treatment of cystic fibrosis patients. Preliminary report.

Authors:  I Sermet-Gaudelus; V Stoven; J P Annereau; V Witko-Sarsat; P Reinert; M Guyot; B Descamps-Latscha; J Y Lallemand; G Lenoir
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

5.  Increased Expression of Plasma-Induced ABCC1 mRNA in Cystic Fibrosis.

Authors:  Justin E Ideozu; Xi Zhang; Amy Pan; Zainub Ashrafi; Katherine J Woods; Martin J Hessner; Pippa Simpson; Hara Levy
Journal:  Int J Mol Sci       Date:  2017-08-11       Impact factor: 5.923

6.  The GCC repeat length in the 5'UTR of MRP1 gene is polymorphic: a functional characterization of its relevance for cystic fibrosis.

Authors:  Elena Nicolis; Matteo Pasetto; Cristina Cigana; Ugo Pradal; Baroukh M Assael; Paola Melotti
Journal:  BMC Med Genet       Date:  2006-02-07       Impact factor: 2.103

7.  Suppressive activity of macrolide antibiotics on nitric oxide production by lipopolysaccharide stimulation in mice.

Authors:  Hajime Terao; Kazuhito Asano; Ken-ichi Kanai; Yoshiyuki Kyo; So Watanabe; Tadashi Hisamitsu; Harumi Suzaki
Journal:  Mediators Inflamm       Date:  2003-08       Impact factor: 4.711
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.